In one of our previous studies, we determined an optimal PSA cutoff level of 1.24 ng/mL for distinguishing between positive and negative PSMA PET/CT results for BC patients after primary prostatectomy (P-P) [13]. This evidence concerns the gene FOLH1 and breast cancer.